BCR-ABL utilizes many pathways—such as PI3K/AKT/mTOR signaling, modulation of Beclin-1 and ATF5 regulation, MAPK signaling, and responses to ER stress—to carefully control autophagy in CML cells. This evidence concerns the gene MTOR and chronic myelogenous leukemia, BCR-ABL1 positive.